Literature DB >> 18255224

Inhibited glutamate release by granulocyte-colony stimulating factor after experimental stroke.

Jun-liang Han1, Tobias Blank, Blank Tobyas, Stefan Schwab, Rainer Kollmar.   

Abstract

We investigated the ability of granulocyte-colony stimulating factor (G-CSF) on inhibiting glutamate release by microdialysis in a rat stroke model. Male Wistar rats (n=15) were treated with either intravenous saline or G-CSF (60 microg/kg) 30 min after temporary middle cerebral artery occlusion (MCAO). G-CSF significantly attenuated the release of glutamate in the infarcted striatum from 30 minutes to 180 minutes after tMCAO compared with control (p<0.05). Infarct volume in G-CSF treated group (135+/-13 mm(3)) reduced significantly compared to control (181+/-10mm(3)) at 24 hours after tMCAO. The result of present study show that G-CSF possess an ability to inhibit excitotoxicity after ischemic stroke.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18255224     DOI： 10.1016/j.neulet.2007.07.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN： 0304-3940            Impact factor:   3.046


  11 in total

Review 1.  Stem cell therapy for cerebral ischemia: from basic science to clinical applications.

Authors:  Koji Abe; Toru Yamashita; Shunya Takizawa; Satoshi Kuroda; Hiroyuki Kinouchi; Nobutaka Kawahara
Journal:  J Cereb Blood Flow Metab       Date:  2012-01-18       Impact factor: 6.200

2.  Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke.

Authors:  Ike dela Peña; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2015-12       Impact factor: 6.829

3.  The activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotection.

Authors:  Alexander Zlotnik; Yael Klin; Benjamin F Gruenbaum; Shaun E Gruenbaum; Sharon Ohayon; Mathew Boyko; Eyal Sheiner; Barak Aricha-Tamir; Yoram Shapira; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

4.  Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy.

Authors:  Shimin Liu; Steven R Levine; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2010-03-15

5.  G-CSF, rt-PA and combination therapy after experimental thromboembolic stroke.

Authors:  Rainer Kollmar; Nils Henninger; Christian Urbanek; Stefan Schwab
Journal:  Exp Transl Stroke Med       Date:  2010-04-14

6.  Granulocyte-Colony Stimulating Factor Reduces Cocaine-Seeking and Downregulates Glutamatergic Synaptic Proteins in Medial Prefrontal Cortex.

Authors:  Rebecca S Hofford; Tanner J Euston; Rashaun S Wilson; Katherine R Meckel; Emily G Peck; Arthur Godino; Joseph A Landry; Erin S Calipari; TuKiet T Lam; Drew D Kiraly
Journal:  J Neurosci       Date:  2020-12-23       Impact factor: 6.709

7.  Granulocyte colony-stimulating factor attenuates delayed tPA-induced hemorrhagic transformation in ischemic stroke rats by enhancing angiogenesis and vasculogenesis.

Authors:  Ike C dela Peña; Arum Yoo; Naoki Tajiri; Sandra A Acosta; Xunming Ji; Yuji Kaneko; Cesar V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-26       Impact factor: 6.200

8.  Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.

Authors:  Ike C Dela Peña; Samuel Yang; Guofang Shen; Hsiao Fang Liang; Sara Solak; Cesar V Borlongan
Journal:  Int J Mol Sci       Date:  2018-05-31       Impact factor: 5.923

Review 9.  Ischemic stroke and repair: current trends in research and tissue engineering treatments.

Authors:  Jian Wang; Wen Yang; Hongjian Xie; Yu Song; Yongkui Li; Lin Wang
Journal:  Regen Med Res       Date:  2014-02-03

Review 10.  Growth factors in ischemic stroke.

Authors:  S Lanfranconi; F Locatelli; S Corti; L Candelise; G P Comi; P L Baron; S Strazzer; N Bresolin; A Bersano
Journal:  J Cell Mol Med       Date:  2009-12-08       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.